Clinical Trials in Dezhou, Shandong
13 recruiting
Showing 1–10 of 10 trials
Recruiting
Phase 2
Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma
HER2-negativeLow PD-L1 ExpressingUnresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Qilu Hospital of Shandong University77 enrolled29 locationsNCT06932068
Recruiting
Not Applicable
Effect of Predictive Model on Double-Balloon Enteroscopy
Double-balloon Enteroscopy
Shandong University338 enrolled5 locationsNCT07288346
Recruiting
Phase 4
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Acute Coronary SyndromeHelicobacter Pylori Infection
Qilu Hospital of Shandong University2,600 enrolled42 locationsNCT04728516
Recruiting
Phase 3
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Ischemic Stroke, Acute
Beijing Tiantan Hospital1,380 enrolled82 locationsNCT06157502
Recruiting
Not Applicable
Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis
Arteriovenous Fistula Stenosis
DK Medical Technology (Suzhou) Co., Ltd.328 enrolled33 locationsNCT06422845
Recruiting
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
Bladder Cancer
Qilu Hospital of Shandong University293 enrolled17 locationsNCT06662071
Recruiting
Phase 4
Efficacy and Safety of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty
Osteoarthritis, Knee
Dezhou Hospital Qilu Hospital of Shandong University60 enrolled1 locationNCT06557018
Recruiting
Phase 3
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）
TIAIschemic Stroke, Acutesymptomatic intracranial artery stenosis
Beijing Tiantan Hospital4,674 enrolled5 locationsNCT06319846
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856
Recruiting
Phase 4
Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
Chronic Coronary Syndrome
Shandong First Medical University1,200 enrolled32 locationsNCT06171061